Doctor of Pharmacy
Medicine, Health and Molecular Sciences
DRE – Doctorate by Research
Completion of a Bachelor of Pharmacy with Honours Class I or IIA or a Bachelor degree with Honours Class I or IIA in an appropriate discipline, approved by the Higher Degrees by Research sub-Committee (HDRS-C) on the advice of the Head of School of Pharmacy and Molecular Sciences; or
Completion of a Master of Pharmacy or Master of Pharmaceutical Public Health with at least a 12-credit point research option with a grade of Credit or above or with research publications deemed to be of equivalent value as considered appropriate by the Head of School; or
Completion of a Masters degree at this or another university in an appropriate health field at a standard and of a nature considered appropriate by the Head of School; or
Other qualifications and experience judged by the Head of School to be equivalent to that above.
Entry requirements for this course are consistent with the Pathways to Qualifications in the Australian Qualifications Framework (AQF) Guidelines for Doctoral degrees
Confirmation of candidature
The candidate shall apply to have their candidature confirmed:
The candidate shall orally, or by electronic communication, present a seminar on the Doctor of Pharmacy work. The candidate’s Supervisory Committee (or their nominees) must attend the seminar and meet after the seminar to discuss the outcome.
The candidate shall present seven days before the seminar, to the Chair of the Higher Degrees by Research Sub-Committee (HDRS-C) through the Principal Supervisor and the Head of the School, a 2000-word project proposal including the aims, methodology, budget, timeline, progress to date and any other academic issues arising from the program of work, together with a second piece of substantive written work, usually a literature review.
The seminar presentation and the proposal shall be reported upon by the members of the Supervisory Committee in a combined report to the HDRS-C.
In considering the reports on the seminar presentation the HDRS-C may interview the candidate, and if appropriate, any member(s) of the Supervisory Committee, and any other relevant person.
The HDRS-C may make suggestions to the candidate as to how the research might be improved and may seek independent peer review. The Principal Supervisor and the Head of the School shall also be informed of such suggestions. The advice provided need not necessarily be accepted by the candidate.
The HDRS-C shall then approve one of the following:
The decision of the HDRS-C on a recommendation shall be conveyed in writing to the candidate within 14 days of the date of the decision together with advice of the candidate’s right of appeal.
Expected time to complete
3 years full time or equivalent part time
Maximum time to complete
Maximum leave of absence
Academic Requirements for Course Completion
Minimum EFTSL (equivalent full-time student load) to complete
EFTSL to complete (equivalent full-time student load)
Additional course rules
A candidate may apply to include up to 12 credit points of appropriate masters level coursework subjects, as approved by the candidate’s supervisory team and provided that these credit points have not also been credited towards another award
Characteristics of learning outcomes for this course are consistent with those outlined in the Doctoral Degree Guideline in the Australian Qualifications Framework (AQF)
PD7216:00 Professional Doctorate Research Thesis (Pharmacy)
PC6015:06 Doctor of Pharmacy Conference Presentations
PC6013:06 Doctor of Pharmacy Clinical Attachment
PC6014:09 Doctor of Pharmacy Extended Clinical Attachment
PC6016:06 Doctor of Pharmacy Specialisation 1
PC6017:06 Doctor of Pharmacy Specialisation 2
PC6018:06 Doctor of Pharmacy Doctoral Project 1
PC6019:06 Doctor of Pharmacy Doctoral Project 2
PC6020:06 Doctor of Pharmacy Doctoral Project 3
Appointment of Supervisors
Candidates shall be assigned a principal supervisor and a co-supervisor who shall be members of the staff of the University and on the Register of Supervisors of the University. At least one associate supervisor may be appointed on account of their professional experience, expertise and special knowledge of the candidate’s intended program of study. Associate supervisors need not be staff members of this University, but should have appropriate expertise and professional experience.
The Principal Supervisor shall report as required to the Higher Degrees by Research Sub-Committee (HDRS-C) on the candidate’s work.
A candidate’s progress shall be reviewed as part of the annual reporting and exit seminar processes.
A candidate shall, at a seminar, present an overview and synthesis of major findings of the thesis in a public forum orally or by electronic communication during the final year of candidature. The candidate’s Supervisory Committee (or their nominees) must attend the seminar and meet after the seminar to discuss the outcome.
The seminar presentation on the work shall be reported upon by the members of the Supervisory Committee in a combined report to the HDRS-C.
The HDRS-C shall then approve one of the following:
The thesis may not be submitted earlier than three years or later than five years from the date of admission. In special circumstances, approved by the Head of School and the Dean of Postgraduate Studies, an extension or variation of this requirement may be granted, provided that the candidate has passed all the required coursework.
Published contributions may be submitted to support or to form part or all of the thesis, provided that they have not been submitted to support or form part of another academic qualification or subject.
The original and two copies of the thesis must be submitted to the Graduate Research School for examination.
Appointment of Examiners
The Higher Degrees by Research Sub-Committee (HDRS-C) will appoint examiners on the advice of the Head of the School of the School of Pharmacy and Molecular Sciences
Examiners will be fully briefed on the nature of the Doctor of Pharmacy program and be made cognisant of the proportion of the course to be assessed through the material they examine.
The examination of the thesis will be administered by the Graduate Research School.
The thesis will be examined by at least two external examiners.
The Higher Degrees by Research Sub-Committee, on the recommendation of the examiners, may require the candidate to undertake a written or oral examination or both on the topic of the thesis.
Examiners’ reports and the recommendations that follow from them will be forwarded to the Head of the School of Pharmacy and Molecular Sciences for recommendation to the Pro-Vice-Chancellor of the faculty.
As per the University appeals procedure for Doctor of Philosophy. See University Requirements for Doctor of Philosophy .
This is a joint degree
Inclusion of field of study on testamur
Higher Degree by Research
Doctorate by Research
Maximum EFTSL to complete
Minimum EFTSL to complete
Maximum funded EFTSL
Alternate course code
RF – RTS Funded
DR – Domestic Research
IR – International Research Fee Paying
Mode Combination 1